The impact of intensive multifactorial treatment on perceptions of chronic care among individuals with screen-detected diabetes: Results from the ADDITION-Denmark trial

International Journal of Clinical Practice

Volumn 69, Issue 4, 2015, Pages 466-473

  Kuznetsov, L ^a   Simmons, R K ^a   Sandbaek, A ^b   Maindal, H T ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; AGED; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DENMARK; DIABETIC PATIENT; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INTENSIVE CARE; INTENSIVE MULTIFACTORIAL THERAPY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT OF CHRONIC ILLNESS CARE; PATIENT ATTITUDE; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; DIABETES MELLITUS, TYPE 2; DIET THERAPY; LIFESTYLE; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOLOGY; SOCIOECONOMICS;

ADULT; AGED; DENMARK; DIABETES MELLITUS, TYPE 2; DIET THERAPY; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; MALE; MIDDLE AGED; PATIENT SATISFACTION; SOCIOECONOMIC FACTORS;

EID: 84925819317     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12570     Document Type: Article

References (38)

1. Kanavos P, Van den Aardweg S, Schurer W,. Diabetes expenditure, burden of disease and management in 5 EU countries: LSE Health, London School of Economics; 2012. http://www2.lse.ac.uk/LSEHealthAndSocialCare/research/LSEHealth/MTRG/LSEDiabetesReport26Jan2012.pdf (accessed May 13, 2014).
2. Wagner J,. Behavioral interventions to promote diabetes self-management. Preface. Diabetes Spectrum 2011; 24 (2): 61-2.
3. Avery L, Flynn D, van Wersch A, Sniehotta FF, Trenell MI,. Changing physical activity behavior in type 2 diabetes: a systematic review and meta-analysis of behavioral interventions. Diabetes Care 2012; 35 (12): 2681-9.
4. Gregg EW, Chen H, Wagenknecht LE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012; 308 (23): 2489-96.
5. Asche C, LaFleur J, Conner C,. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther 2011; 33 (1): 74-109.
6. Wagner EH,. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1998; 1 (1): 2-4.
7. Bodenheimer T, Wagner EH, Grumbach K,. Improving primary care for patients with chronic illness. JAMA 2002; 288 (14): 1775-9.
8. Bodenheimer T, Wagner EH, Grumbach K,. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002; 288 (15): 1909-14.
9. Nutting PA, Dickinson WP, Dickinson LM, et al. Use of chronic care model elements is associated with higher-quality care for diabetes. Ann Fam Med 2007; 5 (1): 14-20.
10. Jenkinson C, Coulter A, Bruster S, Richards N, Chandola T,. Patients' experiences and satisfaction with health care: results of a questionnaire study of specific aspects of care. Qual Saf Health Care 2002; 11 (4): 335-9.
11. Danielsen K, Garratt AM, Bjertnaes OA, Pettersen KI,. Patient experiences in relation to respondent and health service delivery characteristics: a survey of 26,938 patients attending 62 hospitals throughout Norway. Scand J Public Health 2007; 35 (1): 70-7.
12. Narayan KM, Gregg EW, Fagot-Campagna A, et al. Relationship between quality of diabetes care and patient satisfaction. J Nat Med Assoc 2003; 95 (1): 64-70.
13. Alazri MH, Neal RD,. The association between satisfaction with services provided in primary care and outcomes in Type 2 diabetes mellitus. Diabet Med 2003; 20 (6): 486-90.
14. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358 (24): 2545-59.
15. NHS. Putting Prevention First. NHS Health Check: Vascular Risk Assessment and Management. Best Practice Guidance. London: Department of Health, NHS, 2009.
16. Lauritzen T, Griffin S, Borch-Johnsen K, et al. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000; 24 (Suppl. 3): S6-11.
17. Griffin SJ, Borch-Johnsen K, Davies MJ, et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011; 378 (9786): 156-67.
18. Gaede P, Vedel P, Larsen N, Jensen G, Parving H, Pedersen O,. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348 (5): 383-93.
19. Royal College of General Practitioners in Denmark. Type 2 Diabetes in General Practice-Diagnosis and Treatment. Copenhagen, Denmark: Royal College of General Practitioners, 1999.
20. Charles M, Fleischer J, Witte DR, et al. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study. Diabetologia 2013; 56 (1): 101-8.
21. Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35 (8): 1381-95.
22. Glasgow RE, Whitesides H, Nelson CC, King DK,. Use of the Patient Assessment of Chronic Illness Care (PACIC) with diabetic patients: relationship to patient characteristics, receipt of care, and self-management. Diabetes Care 2005; 28 (11): 2655-61.
23. Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM,. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care 2005; 43 (5): 436-44.
24. Wagner EH, Austin BT, Von Korff M,. Organizing care for patients with chronic illness. Milbank Q 1996; 74 (4): 511-44.
25. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH,. Collaborative management of chronic illness. Ann Intern Med 1997; 127 (12): 1097-102.
26. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2007; 30 (Suppl. 1): S4-41.
27. WHO. Obesity and overweight. Fact sheet N-311. Geneva, WHO, 2011. http://www.who.int/mediacentre/factsheets/fs311/en/(accessed May 14, 2014).
28. WHO. A Comprehensive Global Monitoring Framework, Including Indicators, and A Set Of Voluntary Global Targets for the Prevention and Control of Noncommunicabale Diseases. Geneva: WHO, 2012. http://www.who.int/nmh/events/2012/discussion-paper3.pdf (accessed May 14, 2014).
29. Wensing M, van Lieshout J, Jung HP, Hermsen J, Rosemann T,. The Patients Assessment Chronic Illness Care (PACIC) questionnaire in The Netherlands: a validation study in rural general practice. BMC Health Serv Res 2008; 8: 182.
30. Aragones A, Schaefer EW, Stevens D, Gourevitch MN, Glasgow RE, Shah NR,. Validation of the Spanish translation of the Patient Assessment of Chronic Illness Care (PACIC) survey. Prev Chronic Dis 2008; 5 (4): A113.
31. Szecsenyi J, Rosemann T, Joos S, Peters-Klimm F, Miksch A,. German diabetes disease management programs are appropriate for restructuring care according to the chronic care model: an evaluation with the patient assessment of chronic illness care instrument. Diabetes Care 2008; 31 (6): 1150-4.
32. Taggart J, Chan B, Jayasinghe UW, et al. Patients Assessment of Chronic Illness Care (PACIC) in two Australian studies: structure and utility. J Eval Clin Pract 2011; 17 (2): 215-21.
33. Francis V, Korsch BM, Morris MJ,. Gaps in doctor-patient communication. Patients' response to medical advice. N Engl J Med 1969; 280 (10): 535-40.
34. Safran DG, Montgomery JE, Chang H, Murphy J, Rogers WH,. Switching doctors: predictors of voluntary disenrollment from a primary physician's practice. J Fam Pract 2001; 50 (2): 130-6.
35. Janssen PG, Gorter KJ, Stolk RP, Rutten GE,. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study. Br J Gen Pract 2009; 59 (558): 43-8.
36. Webb DR, Khunti K, Gray LJ, et al. Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial. Diabet Med 2012; 29 (4): 531-40.
37. Black JA, Sharp S, Wareham NJ, et al. Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial. Diabet Med 2014; 31 (6): 647-56.
38. Van den Donk M, Griffin SJ, Borch-Johnsen K, et al. Effect of early intensive multifactorial therapy compared to routine care on self-reported health status, general wellbeing, diabetes specific quality of life and treatment satisfaction in screen-detected type 2 diabetes patients: the ADDITION-Europe study. Diabetologia 2013; [Epub ahead of print].